Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Polyps
×
90 days
×
Clear all
Filters
3
NCT06950385
2026-03-17
SERENTA
Rapamycin Holdings Inc.
Phase 3
Recruiting
168 enrolled
NCT04369053
2025-12-26
PREEMPT CRC
Freenome Holdings Inc.
Completed
48,995 enrolled
15 charts